161 related articles for article (PubMed ID: 32104087)
21. Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer.
Ichiki M; Wataya H; Yamada K; Tsuruta N; Takeoka H; Okayama Y; Sasaki J; Hoshino T
Onco Targets Ther; 2017; 10():5107-5113. PubMed ID: 29123409
[TBL] [Abstract][Full Text] [Related]
22. Preventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species production.
Yoshida K; Yoshioka M; Okamura H; Moriyama S; Kawazoe K; Grenier D; Hinode D
PLoS One; 2014; 9(11):e112689. PubMed ID: 25389767
[TBL] [Abstract][Full Text] [Related]
23. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes.
Kono T; Kaneko A; Matsumoto C; Miyagi C; Ohbuchi K; Mizuhara Y; Miyano K; Uezono Y
Integr Cancer Ther; 2014 Sep; 13(5):435-45. PubMed ID: 24501112
[TBL] [Abstract][Full Text] [Related]
24. Effects of Hangeshashinto on the nasal physiological function: An in vitro study.
Tochigi K; Omura K; Miyashita K; Aoki S; Otori N; Tanaka Y
Auris Nasus Larynx; 2021 Apr; 48(2):235-240. PubMed ID: 32859442
[TBL] [Abstract][Full Text] [Related]
25. Effects of ozone nano-bubble water on mucositis induced by cancer chemotherapy.
Hayashi K; Onda T; Honda H; Ozawa N; Ohata H; Takano N; Shibahara T
Biochem Biophys Rep; 2019 Dec; 20():100697. PubMed ID: 31692631
[TBL] [Abstract][Full Text] [Related]
26. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
[TBL] [Abstract][Full Text] [Related]
27. Kampo medicines Rikkunshito and Hangeshashinto prevent cisplatin-induced intestinal mucosal injury in rats.
Zenitani M; Sasaki T; Oue T
J Pediatr Surg; 2021 Jul; 56(7):1211-1218. PubMed ID: 33840504
[TBL] [Abstract][Full Text] [Related]
28. Elemental diet directly affects chemotherapy-induced dermatitis and raw wound areas.
Harada K; Takenawa T; Ferdous T; Mizukami Y; Mishima K
Mol Clin Oncol; 2020 Aug; 13(2):209-215. PubMed ID: 32699632
[TBL] [Abstract][Full Text] [Related]
29. The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase.
Miyano K; Hasegawa S; Asai N; Uzu M; Yatsuoka W; Ueno T; Nonaka M; Fujii H; Uezono Y
Front Pharmacol; 2021; 12():695039. PubMed ID: 35145397
[TBL] [Abstract][Full Text] [Related]
30. Impact of the use of Kampo medicine in patients with esophageal cancer during chemotherapy:a clinical trial for oral hygiene and oral condition.
Moriyama S; Hinode D; Yoshioka M; Sogawa Y; Nishino T; Tangoku A; Grenier D
J Med Invest; 2018; 65(3.4):184-190. PubMed ID: 30282858
[TBL] [Abstract][Full Text] [Related]
31. Comparative studies on the antiallergic effects of kampo medicines used for the therapy of respiratory diseases.
Nyunt AK; Takeuchi Y; Yokomuro K; Miyanaga Y
Arerugi; 1995 Apr; 44(4):503-12. PubMed ID: 7598644
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis.
Hong BY; Sobue T; Choquette L; Dupuy AK; Thompson A; Burleson JA; Salner AL; Schauer PK; Joshi P; Fox E; Shin DG; Weinstock GM; Strausbaugh LD; Dongari-Bagtzoglou A; Peterson DE; Diaz PI
Microbiome; 2019 Apr; 7(1):66. PubMed ID: 31018870
[TBL] [Abstract][Full Text] [Related]
33. Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil.
Yamaguchi K; Ono K; Hitomi S; Ito M; Nodai T; Goto T; Harano N; Watanabe S; Inoue H; Miyano K; Uezono Y; Matoba M; Inenaga K
Pain; 2016 May; 157(5):1004-1020. PubMed ID: 26808144
[TBL] [Abstract][Full Text] [Related]
34. Management of afatinib-induced stomatitis.
Kato S; Saito A; Matsuda N; Suzuki H; Ujiie M; Sato S; Miyazaki K; Kodama T; Satoh H
Mol Clin Oncol; 2017 Apr; 6(4):603-605. PubMed ID: 28413677
[TBL] [Abstract][Full Text] [Related]
35. Effects of Hangeshashinto on Growth of Oral Microorganisms.
Fukamachi H; Matsumoto C; Omiya Y; Arimoto T; Morisaki H; Kataoka H; Kadena M; Funatsu T; Fukutake M; Kase Y; Kuwata H
Evid Based Complement Alternat Med; 2015; 2015():512947. PubMed ID: 26170876
[TBL] [Abstract][Full Text] [Related]
36. Herbal medicines for the treatment of cancer chemotherapy-induced side effects.
Ohnishi S; Takeda H
Front Pharmacol; 2015; 6():14. PubMed ID: 25713534
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters.
Mitsuhashi H; Suemaru K; Li B; Cui R; Araki H
Eur J Pharmacol; 2006 Dec; 551(1-3):152-5. PubMed ID: 17046745
[TBL] [Abstract][Full Text] [Related]
38. The Japanese Herbal (Kampo) Medicine Hochuekkito Attenuates Lung Inflammation in Lung Emphysema.
Isago H; Mitani A; Kohno S; Nagoshi S; Ishimori T; Saito M; Tamiya H; Miyashita N; Ishii T; Matsuzaki H; Yatomi Y; Nagase T; Jo T
Biol Pharm Bull; 2021; 44(1):39-45. PubMed ID: 33390548
[TBL] [Abstract][Full Text] [Related]
39. Author Correction: The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.
Miyano K; Eto M; Hitomi S; Matsumoto T; Hasegawa S; Hirano A; Nagabuchi K; Asai N; Uzu M; Nonaka M; Omiya Y; Kaneko A; Ono K; Fujii H; Higami Y; Kono T; Uezono Y
Sci Rep; 2020 Nov; 10(1):19806. PubMed ID: 33168924
[TBL] [Abstract][Full Text] [Related]
40. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
